Schonfeld Strategic Advisors’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-546,414
| Closed | -$6.75M | – | 2591 |
|
|
2024
Q4 | $6.75M | Buy |
546,414
+334,164
| +157% | +$3.83M | 0.04% | 411 |
|
|
2024
Q3 | $2.42M | Sell |
212,250
-341,703
| -62% | -$3.43M | 0.02% | 808 |
|
|
2024
Q2 | $3.96M | Buy |
553,953
+53,451
| +11% | +$409K | 0.03% | 635 |
|
|
2024
Q1 | $3.35M | Buy |
500,502
+476,009
| +1,943% | +$3.27M | 0.02% | 791 |
|
|
2023
Q4 | $159K | Sell |
24,493
-27,758
| -53% | -$179K | ﹤0.01% | 1568 |
|
|
2023
Q3 | $493K | Sell |
52,251
-13,072
| -20% | -$157K | ﹤0.01% | 1213 |
|
|
2023
Q2 | $913K | Sell |
65,323
-257,483
| -80% | -$4.39M | 0.01% | 1011 |
|
|
2023
Q1 | $6.06M | Buy |
322,806
+101,606
| +46% | +$1.67M | 0.06% | 395 |
|
|
2022
Q4 | $3.05M | Buy |
221,200
+37,939
| +21% | +$581K | 0.03% | 661 |
|
|
2022
Q3 | $3.5M | Buy |
183,261
+83,617
| +84% | +$1.52M | 0.03% | 657 |
|
|
2022
Q2 | $1.52M | Buy |
99,644
+70,044
| +237% | +$1.04M | 0.01% | 835 |
|
|
2022
Q1 | $603K | Sell |
29,600
-23,800
| -45% | -$485K | 0.01% | 1252 |
|
|
2021
Q4 | $1.56M | Sell |
53,400
-18,688
| -26% | -$535K | 0.01% | 765 |
|
|
2021
Q3 | $1.55M | Sell |
72,088
-21,412
| -23% | -$517K | 0.02% | 800 |
|
|
2021
Q2 | $2.4M | Sell |
93,500
-158,000
| -63% | -$3.37M | 0.03% | 657 |
|
|
2021
Q1 | $4.58M | Buy |
251,500
+147,800
| +143% | +$2.46M | 0.06% | 448 |
|
|
2020
Q4 | $1.2M | Buy |
103,700
+16,200
| +19% | +$148K | 0.02% | 750 |
|
|
2020
Q3 | $667K | Buy |
87,500
+48,100
| +122% | +$364K | 0.01% | 823 |
|
|
2020
Q2 | $259K | Buy |
+39,400
| New | +$220K | 0.01% | 1040 |
|
|
2020
Q1 | – | Sell |
-28,600
| Closed | -$219K | – | 1596 |
|
|
2019
Q4 | $219K | Sell |
28,600
-24,200
| -46% | -$141K | 0.01% | 1130 |
|
|
2019
Q3 | $280K | Buy |
+52,800
| New | +$328K | 0.01% | 802 |
|
|
2019
Q2 | – | Sell |
-442,600
| Closed | -$1.88M | – | 1299 |
|
|
2019
Q1 | $1.88M | Sell |
442,600
-228,100
| -34% | -$931K | 0.07% | 354 |
|
|
2018
Q4 | $2.75M | Sell |
670,700
-21,000
| -3% | -$110K | 0.11% | 257 |
|
|
2018
Q3 | $4.75M | Buy |
691,700
+641,700
| +1,283% | +$3.8M | 0.21% | 140 |
|
|
2018
Q2 | $196K | Buy |
+50,000
| New | +$173K | 0.01% | 705 |
|
Other funds holding CDMO
Schonfeld Strategic Advisors's CDMO Position: Q1 2025 in Review
Schonfeld Strategic Advisors sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 546,414 shares — an estimated $6.75M sold.
Schonfeld Strategic Advisors first reported a position in CDMO in Q2 2018 and held it in 25 quarters. The position peaked at $6.75M in Q4 2024. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.
- Schonfeld Strategic Advisors reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
- Schonfeld Strategic Advisors sold 546,414 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $6.75M.
- Schonfeld Strategic Advisors first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2018 and held it in 25 quarters.
- Schonfeld Strategic Advisors's Avid Bioservices, Inc. Common Stock position peaked at $6.75M in Q4 2024.
- 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.
Based on Schonfeld Strategic Advisors's 13F filing for Q1 2025, filed 15 May 2025.